Skip to main content

Want a detailed portfolio tracker?

Castle Biosciences (CSTL) Total Debt (2017 - 2026)

Castle Biosciences (CSTL) total debt from Dec 31, 2017 to Mar 31, 2026. The current Castle Biosciences (CSTL) total debt is $86M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Castle Biosciences (CSTL) Total Debt CAGR table

PeriodCAGR
1 Year TTM+38.51%
3 Years TTM+29.89%
5 Years TTM+23.84%
All Time TTM+40.37%

Annual Total Debt change of Castle Biosciences (CSTL)

YearTotal DebtChange
2025$108M
+42.81%
2024$75M
+21.48%
2023$62M
+28.83%
2022$48M
-5.21%
2021$51M
+115.02%
2020$24M
-31.74%
2019$35M
+6.62%
2018$32M
N/A
2017$0
N/A

Comparison Castle Biosciences (CSTL) total debt with competitors

Castle Biosciences (CSTL) total debt is $86.39M.

TickerNameTotal DebtUpside
ADVBAdvanced Biomed Inc$1.44M-98.34%
NDRAENDRA Life Sciences Inc$1.65M-98.09%
MBAICheckCap Ltd$1.83M-97.89%
CHEKCheck-Cap Ltd$1.83M-97.89%
APDNApplied Dna Sciences Inc$2.95M-96.59%
MYNZMainz Biomed N.V.$3.13M-96.38%
BIAFBioAffinity Technologies Inc$4.28M-95.04%
ISPCiSpecimen Inc$6.44M-92.54%
PRPOPrecipio Inc$6.64M-92.32%
XWELXWELL Inc$14.91M-82.74%
XGNExagen Inc$37.52M-56.56%
IMDXInsight Molecular Diagnostics Inc$51.12M-40.83%
FONRFonar Corp$54.77M-36.61%
PRPHProPhase Labs Inc$58.84M-31.89%
PSNLPersonalis Inc$70.63M-18.24%
BDSXBiodesix Inc$85.50M-1.02%
VCYTVeracyte Inc$91.99M+6.49%
CDNACaredx Inc$97.53M+12.89%
FLGTFulgent Genetics Inc$112.22M+29.89%
MDXHMDxHealth SA$160.05M+85.26%
BLLNBilliontoone Inc - Class A$195.11M+125.84%
TWSTTwist Bioscience Corp$221.12M+155.96%
WGSGeneDx Holdings Corp - Class A$252.18M+191.91%
ADPTAdaptive Biotechnologies Corp$281.70M+226.08%
GRALGRAIL Inc$302.79M+250.49%
BNRBurning Rock Biotech Ltd$304.48M+252.45%
MYGNMyriad Genetics Inc$336.30M+289.28%
NEONeogenomics Inc$523.27M+505.70%
NOTVInotiv, Inc. Common Stock$625.32M+623.83%
OPKOpko Health Inc$652.19M+654.93%
NTRANatera Inc$840.38M+872.77%
MEDPMedpace Holdings Inc$1.53B+1672.54%
IDXXIdexx Laboratories Inc$1.83B+2017.60%
GHGuardant Health Inc$2.10B+2326.63%
RDNTRadnet Inc$2.53B+2831.68%
SHCSotera Health Company$2.61B+2925.11%
EXASExact Sciences Corp$3.46B+3904.60%
MTDMettler-Toledo International Inc$3.71B+4195.40%
CRLCharles River Laboratories International Inc$4.74B+5389.06%
RVTYRevvity Inc$4.81B+5472.23%
AAgilent Technologies Inc$5.94B+6779.27%
ICLRIcon Plc$7.08B+8091.22%
WATWaters Corp$9.24B+10594.52%
LHLaboratory Corp Of America Holdings$10.34B+11870.83%
IQVIQVIA Holdings Inc$23.33B+26900.81%